Paul L. Berns is CEO at ALLOS THERAPEUTICS INC (ALTH). They have made 23 open-market trades across 8 companies since 2006, most recently 2026-06-22.
CIK 0001202769
7 open-market purchases totalling $47.3M since 2006, against 16 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MTSR | 7,523,682 | $530.4M |
| KARD | 15,042,035 | $196.3M |
| LYEL | 1,426,528 | $11.6M |
| NMRA | 7,395,185 | $3.6M |
| ANAC | 230,311 | $2.3M |
| JAZZ | 8,290 | $1.7M |
| CLRB | 117,371 | $134K |
| XNPT | 15,000 | $106K |
| UBX | 3,261 | $653 |
| EQRX | 627,000 | — |
| ALTH | 1,233,323 | — |
| Total | $746.2M |
Shares reported on the most recent Form 4, priced at the 2026-06-24 close. 2 holdings could not be priced and are excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KARD | BUY | 2026-06-22 | 2026-06-24 | $16.00 | $20.0M | +6.9% | -6.9% | -26.2% |
| LYEL | BUY | 2026-03-06 | 2026-03-09 | $25.61 | $12.5M | -21.1% | -12.0% | -53.3% |
| NMRA | SELL | 2026-02-17 | 2026-02-19 | $3.51 | $34K | -12.1% | -29.0% | -50.3% |
| NMRA | SELL · 10b5-1 | 2025-02-18 | 2025-02-20 | $1.69 | $23K | -18.0% | -30.2% | -56.1% |
| MTSR | BUY | 2025-02-03 | 2025-02-03 | $18.00 | $14.2M | +6.6% | -6.2% | -14.8% |
| JAZZ | SELL | 2021-08-05 | 2021-08-09 | $154.00 | $223K | -12.6% | -10.3% | -11.4% |
| JAZZ | SELL | 2020-11-04 | 2020-11-04 | $150.47 | $1.4M | -6.7% | -3.8% | +0.4% |
| JAZZ | SELL | 2020-08-07 | 2020-08-10 | $125.87 | $234K | -2.0% | +10.9% | +15.0% |
| JAZZ | SELL | 2019-08-09 | 2019-08-12 | $135.65 | $197K | -3.2% | -1.3% | -3.1% |
| JAZZ | SELL | 2018-08-10 | 2018-08-13 | $176.61 | $233K | -3.5% | -5.6% | -15.5% |
| JAZZ | SELL | 2017-08-11 | 2017-08-14 | $142.36 | $188K | +2.7% | +5.7% | -5.5% |
| JAZZ | SELL | 2016-08-15 | 2016-08-17 | $136.45 | $86K | -7.5% | -8.0% | -18.0% |
| JAZZ | SELL | 2016-08-15 | 2016-08-17 | $136.45 | $86K | -7.5% | -8.0% | -18.0% |
| CLRB | BUY | 2016-04-20 | 2016-04-21 | $2.12 | $498K | -9.7% | +108.7% | +31.8% |
| ANAC | SELL | 2016-03-22 | 2016-03-22 | $60.31 | $2.3M | +2.3% | +4.8% | +65.1% |
| ANAC | SELL | 2016-01-04 | 2016-01-05 | $112.33 | $249K | -16.7% | -30.2% | -45.4% |
| ANAC | SELL | 2016-01-04 | 2016-01-05 | $112.37 | $560K | -16.7% | -30.2% | -45.4% |
| ANAC | SELL · 10b5-1 | 2015-12-11 | 2015-12-15 | $117.26 | $2.3M | -19.4% | -16.1% | -39.7% |
| ANAC | SELL · 10b5-1 | 2015-09-15 | 2015-09-17 | $139.82 | $2.8M | -19.4% | +2.3% | +2.3% |
| ANAC | SELL · 10b5-1 | 2015-08-13 | 2015-08-17 | $138.70 | $2.8M | -19.4% | +2.3% | +2.3% |
| JAZZ | SELL | 2015-08-10 | 2015-08-11 | $180.00 | $144K | -10.8% | -0.4% | -0.4% |
| ANAC | SELL · 10b5-1 | 2015-04-24 | 2015-04-28 | $63.64 | $3.2M | -19.4% | +2.3% | +2.3% |
| ANAC | SELL · 10b5-1 | 2015-03-19 | 2015-03-23 | $56.07 | $2.1M | -19.4% | +2.3% | +2.3% |
| ANAC | SELL · 10b5-1 | 2014-12-26 | 2014-12-29 | $30.82 | $771K | -19.4% | +2.3% | +2.3% |
| JAZZ | SELL | 2014-08-12 | 2014-08-14 | $133.15 | $145K | -10.8% | -0.4% | -0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.